The drug, rilpivirine, may also be effective against other mosquito-borne viral diseases.

Researchers from the Lewis Katz School of Medicine and partner institutions developed a tool that will aid in the search for a new class of painkillers with fewer side effects.

A gift from a Temple trustee will create a new hub for researching the disease.

Robert Bagramian, a 1960 graduate, will bequeath $700,000 to support future dentistry students.

The At Your Service Volunteer Intern Program has dramatically increased the number of student interns from 15 to 85 in about four years.

Receiving more than 10,500 applications for fall 2016, the Lewis Katz School of Medicine is among the nation’s most sought-after medical schools.

Polina Gross, a Lewis Katz School of Medicine PhD candidate, is exploring new ways to treat heart disease.

The scientists at the Lewis Katz School of Medicine are the first to demonstrate HIV can be removed from cells, preventing further infection.

Four Temple researchers were recruited to join the Mayor’s Task Force to Combat the Opioid Epidemic.

A study at the Lewis Katz School of Medicine identified a protein that could serve as an alternative drug target in treatment of the disease.

Temple has advanced seven projects and three startups through the Pharma Germinator, a partnership with Janssen Pharmaceuticals.

A Temple University doctor-in-training who suffered serious injuries in a car crash wrote about what he learned as a patient.